Bit more insight into what Peros is working on.
Interesting
New Innovations were made in the diamagnetic delivery fields, to further enhance the power and capabilities of the Companies Patent Portfolio in magnetic enhanced drug and ingredient delivery. Specific strides were made in limiting lateral spread of ingredients while increasing penetration flux rates.
In new areas, the R&D team created a breakthrough in ingredient delivery by eliminating the need for heavy formulation chassis.
In a new system code named CDT or Condensation Deposition Technology, ingredient molecules are bought to their highest thermokinetic energy levels and deposited as a micro-fine layer that avoids the needs for heavy base creams.
CDT will form the basis on which the Company’s first round of Branded products will be developed with the help of Paul Peros. Designs, branding and product capabilities are all closely guarded secrets ahead of the first branded product launch anticipated to be in early 2020.
- Forums
- ASX - By Stock
- WFL
- Ann: 2019 Appendix 4E
WFL
wellfully limited
Add to My Watchlist
0.00%
!
0.3¢

Ann: 2019 Appendix 4E, page-3
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.478M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
WFL (ASX) Chart |
Day chart unavailable
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online